Royalty Pharma plc (RPRX)
Royalty Pharma plc Operating Income margin
| Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income margin | 48.1% | 38.5% | 58.8% | 76.0% | 144.6% | 75.2% | 62.5% | 43.7% | 63.4% |
Royalty Pharma plc (RPRX) Operating Income margin comparison analysis
RPRX key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Royalty Pharma plc's Operating Income margin?
As of today, Microsoft Corp's last 12-month Operating Income margin is 68.1%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Operating Income margin for Royalty Pharma plc have been 52.9% over the past three years, and 75.5% over the past five years.
2) Is Royalty Pharma plc's Operating Income margin Good?
As of today, Royalty Pharma plc's Operating Income margin is 68.1%, which is higher than industry median of (915.3%). It indicates that Royalty Pharma plc's Operating Income margin is Good.